Induction of systemic immunity through nasal-associated lymphoid tissue (NALT) of mice intranasally immunized with Brucella abortus malate dehydrogenase-loaded chitosan nanoparticles-Reference-Cited by-同舟云学术

Induction of systemic immunity through nasal-associated lymphoid tissue (NALT) of mice intranasally immunized with Brucella abortus malate dehydrogenase-loaded chitosan nanoparticles

Published:2020-02-06 Issue:2 Volume:15 Page:e0228463
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Shim Soojin,Soh Sang Hee^ORCID,Im Young Bin,Ahn Choonghyun,Park Hong-Tae,Park Hyun-Eui,Park Woo Bin,Kim Suji,Yoo Han Sang^ORCID

Funder

MAFRA

KHID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. Brucellosis—regionally emerging zoonotic disease?;M Gwida;Croatian medical journal,2010

2. Meta-Analysis and Advancement of Brucellosis Vaccinology;TF Carvalho;PloS one,2016

3. Identification of Brucella abortus genes in elk (Cervus elaphus) using in vivo-induced antigen technology (IVIAT) reveals novel markers of infection;JE Lowry;Veterinary microbiology,2010

4. Vaccination with Brucella abortus recombinant in vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infection;JE Lowry;PloS one,2011

5. Cytokines production and toll-like receptors expression in human leukemic monocyte cells, THP-1, stimulated with Brucella abortus cellular antigens;YB Im;Microbial pathogenesis,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of Intranasal Active Pharmaceutical Ingredient Delivery Systems;Pharmaceuticals;2024-09-07

2. Chitosan Nanoparticles for Intranasal Drug Delivery;Pharmaceutics;2024-05-31

3. Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review;Vaccines;2023-09-19

4. BCG vaccine-induced mucosal humoral immunity in human nasal associated lymphoid tissue;Journal of King Saud University - Science;2023-08

5. Aerosol pulmonary immune engineering;Advanced Drug Delivery Reviews;2023-08